CVI Investments, Inc. 13D and 13G filings for Salarius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 10:07 am Unchanged | 2020-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX | CVI Investments, Inc. | 4,022 4.100% | 0 (Unchanged) | Filing |
| 2020-02-14 08:58 am Purchase | 2020-02-07 | 13G | Salarius Pharmaceuticals, Inc. SLRX | CVI Investments, Inc. | 4,022 6.900% | 4,022 (New Position) | Filing |